Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review

INTRODUCTION: Cardiovascular disease is a leading cause of mortality in people with type 2 diabetes mellitus (T2DM). Beginning in 2015, long-term cardiovascular outcomes trials (CVOTs) have reported cardioprotective benefits for two classes of diabetes drugs. In addition to improving the lives of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Michael, Asseburg, Christian, Nilsson, Andreas, Neslusan, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778555/
https://www.ncbi.nlm.nih.gov/pubmed/31446570
http://dx.doi.org/10.1007/s13300-019-00681-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778555/
https://www.ncbi.nlm.nih.gov/pubmed/31446570
http://dx.doi.org/10.1007/s13300-019-00681-4

Ejemplares similares